Company Filing History:
Years Active: 2015
Title: Innovations of Jaanos Tibor Kodra
Introduction
Jaanos Tibor Kodra is a notable inventor based in Koebenhavn OE, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of insulin analogues. His work focuses on creating innovative solutions that enhance the administration of insulin for diabetes management.
Latest Patents
Jaanos holds a patent for "Protease stabilized, acylated insulin analogues." This novel acylated insulin analogue exhibits resistance towards proteases, allowing for effective pulmonary or oral administration. The insulin analogues developed by Kodra contain specific modifications, including B25H and A14E or A14H, which enhance their stability and efficacy.
Career Highlights
Kodra is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. His work at Novo Nordisk has positioned him at the forefront of insulin research and development. With a focus on improving patient outcomes, Kodra's innovations are paving the way for more effective diabetes treatments.
Collaborations
Throughout his career, Jaanos has collaborated with esteemed colleagues such as Peter Madsen and Thomas Boerglum Kjeldsen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in insulin technology.
Conclusion
Jaanos Tibor Kodra's contributions to the field of insulin analogues represent a significant advancement in diabetes care. His innovative approach and dedication to research continue to impact the lives of many individuals living with diabetes.